Status:
COMPLETED
A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Pneumonia, Bacterial
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study will assess the efficacy and safety of intravenous beta-lactam, in comparison with ceftriaxone, in hospitalized patients with community-acquired pneumonia not caused by Legionella. The anti...
Eligibility Criteria
Inclusion
- male or female patients at least 18 years of age;
- hospitalization with community-acquired pneumonia or development of pneumonia within 48 hours of being hospitalized for another reason;
- fever;
- new or increased productive cough;
- chest pain, shortness of breath, or rapid breathing.
Exclusion
- requiring intubation or ventilation;
- nursing home or extended care within 60 days before study;
- concomitant bacterial infection requiring antibiotics;
- long-term immunosuppressive therapy.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT00111644
Start Date
March 1 2005
End Date
January 1 2007
Last Update
November 2 2016
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
New Orleans, Louisiana, United States, 70112
2
Shreveport, Louisiana, United States, 71105
3
Detroit, Michigan, United States, 48201
4
Butte, Montana, United States, 59701